Figure 8From: Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trialsMortality and unfavorable outcome according to clazosentan dose. Subgroup analysis for mortality and unfavorable outcome at the end of follow-up according to the dose of clazosentan. CI, confidence interval; df, degrees of freedom M-H, Mantel-Haenszel.Back to article page